Viridian Therapeutics Inc
VRDN
|
$15.17
0.6%
180K
|
Health Care and Social Assistan...
(0.0% 1d) (-12.4% 1m) (-48.4% 1y) (0.0% 2d) (-0.1% 3d) (-5.1% 7d) (-2.73% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 952,184,037
http://www.miragen.com/
Sec Filling | Patents | 27 employees
(US) Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado , with research and development operations in Waltham, Massachusetts.
treatment antibody
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 54% | 46% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.7 44.39% 30.74% 58M
|
XPON | $2.63 36.27% 8.4M
|
PRTG | $0.299 35.17% 120K
|
Mining, Quarrying, and Oil and ...
KULR | $0.39 -18.77% 6.4M
|
Manufacturing
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.6 26.82% 21.15% 260K
|
n/a
Last 48 Hours Insiders Buying
FAST P 3350 | $67.7 -1.14% 1.4M
|
Distribution Services
|
20:00
QCRH | $55.295 1.13% 22K
|
Finance
|
18:01
RVP P 15363 | $1.035 -0.48% 92K
|
Health Technology
|
18:00
VUZI | $1.33 9.02% 540K
|
Electronic Technology
|
18:00
TPL P 3 | $582.57 -0.41% 0.0% 63K
|
Miscellaneous
|
15:00
RELL | $10.055 1.98% 60K
|
Electronic Technology
|
13:30
IZEA | $2.53 20K
|
Technology Services
|
00:00
RKT P 383 | $11.585 1.8% 1.1M
|
Finance
|
22:30
CTRN P 18090 | $22.39 0.09% 33K
|
Retail Trade
|
22:00
BRN P 10650 | $2.8 0.36% 53K
|
Energy Minerals
|
21:00
NEOG P 10000 | $11.85 -2.39% 1.7M
|
Health Technology
|
16:30
RMCF | $3.61 2.27% 18K
|
Consumer Non-Durables
|
20:10